ROYAL BANK OF CANADA
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1000275
TORONTO, A6
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$496,494,870
-$45,049,084 QoQ
Shares Held
1,111,871
-6.9% QoQ
Ownership
0.438%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.52887610163408.ToString("F0")%
Shared 0.8093564811025739.ToString("F0")%
None 0.6617674172633337.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2025CallValue
$45,336,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $1,974,323,419 across 406 Biotechnology names. VRTX ranks #1 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,111,871 | $496,494,870 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,801,815 | $285,478,282 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
351,171 | $271,328,756 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
791,515 | $261,888,563 | |
| 5 | INCY |
Incyte Corp
|
1,054,123 | $99,214,053 | |
| 6 | INSM |
INSMED Inc
|
523,101 | $85,537,473 | |
| 7 | MRNA |
Moderna, Inc.
|
999,340 | $50,766,470 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
658,290 | $42,545,279 |
All Filings in VRTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $496,494,870 | 1,111,871 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $541,543,954 | 1,194,512 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $45,336,000 | 100,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $467,504,189 | 1,193,709 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $616,320,627 | 1,384,368 | Shares | Other | 2025-11-21 | |
| 2025-03-31 | $585,986,413 | 1,208,668 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $584,301,184 | 1,450,959 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $729,076,146 | 1,567,636 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $788,199,544 | 1,681,600 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $209,005 | 500 | Put | Defined | 2024-11-05 | |
| 2024-03-31 | $631,698,378 | 1,511,204 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $591,810,106 | 1,454,472 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $427,788,350 | 1,230,196 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $428,473,644 | 1,217,566 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $354,666,733 | 1,125,676 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $277,353,546 | 960,432 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $267,314,904 | 923,240 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $249,450,366 | 885,235 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $219,239,587 | 840,095 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $154,532,296 | 703,699 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $141,591,216 | 780,590 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $216,175,783 | 1,072,141 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $180,846,692 | 841,578 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $207,258,121 | 876,949 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $198,628,274 | 729,929 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $169,360,461 | 583,378 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $126,846,144 | 533,079 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||